Trials / Completed
CompletedNCT04217239
A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
A Comparison of Short-term and Long- Term Outcomes Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 272 (actual)
- Sponsor
- The Second Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Surgery is still the main treatment for esophageal cancer, however, the complication and mortality rate of open esophagectomy is high. As a result, the thoracoscopic- laparoscopic minimally invasive esophagectomy (MIE) was developed. The MIE mainly comprised two surgical approaches: MIE McKeown approach (cervical anastomosis) and MIE Ivor-Lewis approach (intrathoracicanastomosis). The MIE with intrathoracic anastomosis (Ivor-Lewis) is increasingly used for the treatment of mid and lower esophageal cancers. Our study is trying to compare the safety, feasibility, and short-term and long- term outcomes between MIE Ivor-Lewis approach and MIE McKeown approach for the treatment of lower thoracic esophageal cancer and esophageal- gastric junction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MIE Ivor- Lewis | minimally invasive esophagectomy (MIE) with intrathoracic anastomosis |
| PROCEDURE | MIE McKeown | minimally invasive esophagectomy (MIE) with cervical anastomosis |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2020-01-03
- Last updated
- 2026-02-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04217239. Inclusion in this directory is not an endorsement.